BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 2912409)

  • 1. Composite Pheochromocytoma-Ganglioneuroma of the Adrenal Gland: An Uncommon Entity with Distinctive Clinicopathologic Features.
    Lam KY; Lo CY
    Endocr Pathol; 1999; 10(4):343-352. PubMed ID: 12114771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma.
    Koshida H; Miyamori I; Soma R; Matsubara T; Okamoto S; Ikeda M; Takeda R
    J Endocrinol Invest; 1990 Nov; 13(10):807-15. PubMed ID: 2096157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus as presenting feature in extra-adrenal pheochromocytoma: report of a case.
    Balestrieri PG; Spandrio S; Romanelli G; Giustina G
    Acta Diabetol Lat; 1990; 27(3):261-5. PubMed ID: 2075789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Endocrine Tests. C: glucagon and clonidine test in phaeochromocytoma.
    Bisschop PH; Corssmit EP; Baas SJ; Serlie MJ; Endert E; Wiersinga WM; Fliers E
    Neth J Med; 2009 Mar; 67(3):91-5. PubMed ID: 19307679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Merits of the assay of plasma catecholamines in a glucagon test to diagnosis of pheochromocytoma (author's transl)].
    Bernheim C; Jaillon P; Graisely B; Cloarec M; Debray J; Cheymol G
    Nouv Presse Med; 1978 Feb; 7(7):553-5. PubMed ID: 643581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The glucagon test and diagnosis of pheochromocytoma].
    von Studnitz W
    Schweiz Med Wochenschr; 1970 Jun; 100(24):1023-6. PubMed ID: 5524969
    [No Abstract]   [Full Text] [Related]  

  • 7. The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls.
    Sjoberg RJ; Simcic KJ; Kidd GS
    Arch Intern Med; 1992 Jun; 152(6):1193-7. PubMed ID: 1599347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Test with clonidine for diagnosing pheochromocytoma].
    Wocial B; Chojnowski K; Chodakowska J; Feltynowski T; Lazecki D; Januszewicz W
    Pol Tyg Lek; 1991 Aug 26-Sep 2; 46(35-36):641-5. PubMed ID: 1845684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved safety of glucagon testing for pheochromocytoma by prior alpha-receptor blockade. A controlled trial in a patient with a mixed ganglioneuroma/pheochromocytoma.
    Elliott WJ; Murphy MB; Straus FH; Jarabak J
    Arch Intern Med; 1989 Jan; 149(1):214-6. PubMed ID: 2912409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pheochromocytoma: advances in diagnosis and treatment.
    Pertsemlidis D; Gitlow SE; Kark AE
    Surg Annu; 1972; 4():345-57. PubMed ID: 4589383
    [No Abstract]   [Full Text] [Related]  

  • 11. Pheochromocytoma: challenges in diagnosis and nursing care.
    Daub KF
    Nurs Clin North Am; 2007 Mar; 42(1):101-11, viii. PubMed ID: 17270594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern management of pheochromocytoma.
    Kasturi S; Kutikov A; Guzzo TJ; Smith AL; Wein AJ
    Nat Clin Pract Urol; 2007 Nov; 4(11):630-3. PubMed ID: 17982440
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.